Disease progression in HIV-1 controllers; uptake and outcome of antiretroviral therapy

被引：0
|
作者：
Deayton, J. [1 ]
O'Sullivan, E. [1 ]
McKnight, A. [1 ]
Groves, K. [2 ]
Bibby, D. [2 ]
Clark, D. [2 ]
Orkin, C. [2 ]
Reeves, I. [3 ]
Anderson, J. [3 ]
机构：
[1] Queen Mary Univ, London, England
[2] Barts Hlth NHS Trust, London, England
[3] Homerton Univ Hosp NHS Fdn Trust, London, England
来源：
HIV MEDICINE | 2015年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P27
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania
    Stete, Katarina
    Glass, Tracy R.
    van Dam, Govert J.
    Ntamatungiro, Alex
    Letangz, Emilio
    de Dood, Claudia J.
    Corstjens, Paul L. A. M.
    Ndege, Robert
    Mapesi, Herry
    Kern, Winfried, V
    Hatz, Christoph
    Weisser, Maja
    Utzinger, Juerg
    Mueller, Matthias C.
    PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (10):
  • [42] Early antiretroviral therapy reduces HIV-1 DNA following perinatal HIV-1 infection
    Foster, C.
    Kaye, S.
    Fidler, S.
    Pace, M.
    Jones, M.
    Hopkins, E.
    Robinson, N.
    Frater, J.
    HIV MEDICINE, 2015, 16 : 6 - 6
  • [43] HIV-1 patients with highly antiretroviral therapy (HAART): Potential coronary disease patients
    Ledant, S
    Bonjean, K
    Cayeux, K
    Ausloos, F
    Marot, V
    Cheramy-Bien, JP
    Defraigne, JO
    Piette, J
    Moutschen, M
    Pincemail, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 : S129 - S129
  • [44] Uptake of Combination Antiretroviral Therapy and HIV Disease Progression According to Geographical Origin in Seroconverters in Europe, Canada, and Australia
    Jarrin, Inma
    Pantazis, Nikos
    Gill, M. John
    Geskus, Ronald
    Perez-Hoyos, Santiago
    Meyer, Laurence
    Prins, Maria
    Touloumi, Giota
    Johnson, Anne
    Hamouda, Osamah
    Garcia de Olalla, Patricia
    Porter, Kholoud
    del Amo, Julia
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (01) : 111 - 118
  • [45] HIV-1 subtype as a determinant of disease progression
    Kuritzkes, Daniel R.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05): : 638 - 639
  • [46] HIV-1 evolution and disease progression - Response
    Wolinsky, SM
    Kunstman, KJ
    Safrit, JT
    Koup, RA
    Neumann, AU
    Korber, BTM
    SCIENCE, 1996, 274 (5289) : 1010 - 1011
  • [47] Novel biomarkers for HIV-1 disease progression
    Taylor, Tracey
    Ghorpade, Anuja
    Borgmann, Kathleen
    Pandya, Anjani
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [48] Novel biomarkers for HIV-1 disease progression
    Taylor, Tracey
    Pandya, Anjani
    Borgmann, Kathleen
    Ghorphade, Anuja
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [49] HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1 - Infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine
    Gilbert, PB
    Ackers, ML
    Berman, PW
    Francis, DP
    Popovic, V
    Hu, DJ
    Heyward, WL
    Sinangil, F
    Shepherd, BE
    Gurwith, M
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06): : 974 - 983
  • [50] Restriction Factors in HIV-1 Disease Progression
    Merindol, Natacha
    Berthoux, Lionel
    CURRENT HIV RESEARCH, 2015, 13 (06) : 448 - 461
12345